Tandem high‐dose chemotherapy with autologous stem cell rescue for stage M high‐risk neuroblastoma: Experience using melphalan/etoposide/carboplatin and busulfan/melphalan regimens

2020 ◽  
Vol 24 (7) ◽  
Author(s):  
Shota Kato ◽  
Yasuo Kubota ◽  
Kentaro Watanabe ◽  
Keita Hogetsu ◽  
Yuki Arakawa ◽  
...  
Keyword(s):  
Stem Cell ◽  
High Risk ◽  
High Dose Chemotherapy ◽  
High Dose ◽  
Stem Cell Rescue ◽  
Autologous Stem Cell Rescue

scholarly journals Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma

2014 ◽  
Vol 61 (8) ◽  
pp. 1350-1356 ◽  
Author(s):  
Alissa Martin ◽  
Jennifer Schneiderman ◽  
Irene B. Helenowski ◽  
Elaine Morgan ◽  
Kimberley Dilley ◽  
...  
Keyword(s):  
Stem Cell ◽  
High Risk ◽  
High Dose Chemotherapy ◽  
Malignant Neoplasms ◽  
High Dose ◽  
Stem Cell Rescue ◽  
Autologous Stem Cell Rescue

High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors

2005 ◽  
Vol 71 (1) ◽  
pp. 33-38 ◽  
Author(s):  
Antonio P�rez-Mart�nez ◽  
Alvaro Lassaletta ◽  
Marta Gonz�lez-Vicent ◽  
Juli�n Sevilla ◽  
Miguel Angel D�az ◽  
...  
Keyword(s):  
Stem Cell ◽  
High Risk ◽  
High Dose Chemotherapy ◽  
High Dose ◽  
Primitive Neuroectodermal Tumors ◽  
Stem Cell Rescue ◽  
Neuroectodermal Tumors ◽  
Autologous Stem Cell Rescue
Sign in / Sign up

Export Citation Format

Share Document